Indiana medication assisted treatment program (IMAP) - the indiana division of mental health and addiction (DMHA) proposes the indiana medication assisted treatment program (IMAP) to expand/enhance…

Indiana medication assisted treatment program (IMAP) - the indiana division of mental health and addiction (DMHA) proposes the indiana medication assisted treatment program (IMAP) to expand/enhance access to medication-assisted treatment (mat) services, delivering FDA-approved medications in combination with comprehensive and evidence-based psychosocial services for 2,575 unduplicated adults (18+) with an opioid use disorder (OUD) seeking or receiving mat across a 25 county catchment area in indiana (YR. 1: 475; YRS. 2-5: 525, annually). IMAP's focus population includes individuals seeking or receiving mat from among approximately 14,850 in the catchment area expected to have OUD. Focus population demographics are expected to mirror those of catchment area residents, with 46% male, 54% female, 76% white, 15% african american, and 8% hispanic/latino individuals. IMAP's subpopulations with OUD include an estimated 6,282 veterans; 3,762 criminal justice-involved adults; and 11,880 with a CO-occurring substance use and/or mental health disorder (COD). Of catchment area individuals expected to have OUD, an estimated 72% (10,961) will have polysubstance use, 60% (8,900) will experience severe economic distress, 57% (8,463) will face major depressive disorder, and 57% (8,463) may become homeless. DMHA will partner with centerstone of indiana and porter-starke services to deliver medication-assisted treatment (mat) according to samhsa's treatment improvement protocol (tip) 63: medications for opioid use disorders, providing FDA-approved medications in conjunction with evidence-based behavioral health therapies, such as cognitive behavioral therapy, motivational interviewing, integrating dialectic behavioral therapy with the 12 steps, and evidence-based treatment of tobacco dependence. Key IMAP strategies/interventions include community collaborations; participation in DMHA's opioid treatment provider director meetings; enhancement of program procedures, including mitigation of medication diversion; outreach/engagement; screenings/assessments; development of individual treatment plans; provision of mat, OUD/COD treatment/psychosocial services, tobacco cessation, care coordination, recovery support services (e.g., peer supports, linkages to housing/employment, benefits enrollment); HIV/HCV counseling and testing linkages; telehealth services; sustainability planning; and dissemination of a comprehensive evaluation. IMAP goals are to enhance/expand access to mat services, OUD treatment, wrap-around/recovery supports, etc.; develop infrastructure/capacity to expand, enhance, and sustain services; improve clients' health status/outcomes; and develop/disseminate a replicable service model. IMAP will achieve the following measurable objectives: conduct outreach/engagement among 750 individuals; provide training/workforce development for 100 staff/community providers; ensure data waiver training for 5 practitioners; reduce past 30-day illicit drug use by 60%; reduce mental health symptomatology by 50%; assist 100% in need with resources to identify/secure stable housing and employment; reduce past 30-day criminal justice involvement among 60%; reduce tobacco use by 30%; reduce costly service utilization by 50%; increase social connectedness among 70%; and achieve 80% client retention. IMAP has secured commitments from partners dedicated to the project's success, and will collaborate with community providers, law enforcement, coalitions, social service agencies, key stakeholders, etc.